- Home
- EXAS vs KMX Comparison
EXAS vs KMX Comparison
Compare EXAS & KMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- KMX
- Stock Information
- Founded
- EXAS 1995
- KMX 1993
- Country
- EXAS United States
- KMX United States
- Employees
- EXAS 7000
- KMX N/A
- Industry
- EXAS Medical Specialities
- KMX Retail-Auto Dealers and Gas Stations
- Sector
- EXAS Health Care
- KMX Consumer Discretionary
- Exchange
- EXAS Nasdaq
- KMX Nasdaq
- Market Cap
- EXAS 10.6B
- KMX 8.7B
- IPO Year
- EXAS N/A
- KMX 1997
- Fundamental
- Price
- EXAS $56.85
- KMX $46.24
- Analyst Decision
- EXAS Strong Buy
- KMX Buy
- Analyst Count
- EXAS 21
- KMX 14
- Target Price
- EXAS $67.38
- KMX $64.92
- AVG Volume (30 Days)
- EXAS 2.4M
- KMX 5.3M
- Earning Date
- EXAS 11-04-2025
- KMX 09-25-2025
- Dividend Yield
- EXAS N/A
- KMX N/A
- EPS Growth
- EXAS N/A
- KMX 28.08
- EPS
- EXAS N/A
- KMX 3.40
- Revenue
- EXAS $2,939,949,000.00
- KMX $28,279,819,000.00
- Revenue This Year
- EXAS $16.68
- KMX N/A
- Revenue Next Year
- EXAS $12.08
- KMX $4.30
- P/E Ratio
- EXAS N/A
- KMX $13.55
- Revenue Growth
- EXAS 12.55
- KMX 2.17
- 52 Week Low
- EXAS $38.81
- KMX $42.75
- 52 Week High
- EXAS $72.83
- KMX $91.25
- Technical
- Relative Strength Index (RSI)
- EXAS 68.50
- KMX 25.93
- Support Level
- EXAS $52.85
- KMX $44.19
- Resistance Level
- EXAS $54.74
- KMX $47.44
- Average True Range (ATR)
- EXAS 1.44
- KMX 1.71
- MACD
- EXAS 0.16
- KMX -1.16
- Stochastic Oscillator
- EXAS 98.66
- KMX 18.47
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About KMX CarMax Inc
CarMax sells, finances, and services used and new cars through a chain of around 250 used retail stores. It was formed in 1993 as a unit of Circuit City and spun off into an independent company in late 2002. Used-vehicle sales were 83% of fiscal 2025 revenue and wholesale about 17%, with the remaining portion composed of extended service plans and repair. In fiscal 2025, the company retailed and wholesaled 789,050 and 544,312 used vehicles, respectively. CarMax is the largest used-vehicle retailer in the US but still estimates that it had only about 3.7% US market share of vehicles 0-10 years old in calendar 2024. It seeks over 5% share. CarMax is based in Richmond, Virginia.